Select patients with a normal contralateral kidney who have small ... While upper-tract transitional cell carcinoma (TCC) accounts for only 5% of urothelial malignancies, evidence suggests ...

kidney cancer (renal cell cancer), thymoma (thymic epithelial tumor), transitional cell cancer (urothelial cell cancer), duodenal cancer, lung cancer, ocular melanoma pancreatic cancer, rectal cancer, ...

According to GlobalData, Phase II drugs for Transitional Cell Cancer (Urothelial Cell Cancer ... pancreatic ductal adenocarcinoma (PDAC), metastatic pancreatic cancer, vulvar cancer and metastatic ...

Advanced transitional-cell carcinoma of the bladder is the most ... Nevertheless, 40–50% of patients have impaired renal function that precludes the use of cisplatin. The non-nephrotoxic ...

Treatment for renal cell carcinoma can vary depending on the size of your tumor, your overall health, how advanced your cancer is, and other factors. Some of the options include surgery, radiation ...

From the reveal of NBA star Dwyane Wade’s cancer surgery to a Bachelorette star on her husband’s cancer diagnosis, here is ...

Figure 1: Characterization of the hybrid cell vaccine. The hybrid cell vaccination was well tolerated by all patients. There were no serious adverse effects or any clinical signs of autoimmune ...

According to the American Cancer Society (ACS), about 81,800 people in the U.S. are expected to be diagnosed with kidney and renal pelvic cancers in 2023. The most common type is called renal cell ...

Clear cell renal cell carcinoma (ccRCC or KIRC) has a high mortality rate globally. It is necessary to identify biomarkers and investigate the mechanisms those biomarkers are associated with, to ...

Personalized cancer vaccines showed significant immune responses in stage III/IV renal cell carcinoma patients, with T-cells increasing 166-fold and persisting for up to three years. The vaccine ...